Related Experiment Video
Updated: Jan 4, 2026

Real-time Live Imaging of T-cell Signaling Complex Formation
Published on: June 23, 2013
TAOK3, a Regulator of LCK-SHP-1 Crosstalk during TCR Signaling
João V S Ormonde1, Yan Nie2, Joaquin Madrenas1
1Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California; Microbiome and Disease Tolerance Centre, and Department of Microbiology and Immunology, McGill University, Montréal, Quebec.
Abstract:
Signaling from the T cell receptor for antigen turns on the physiological response of a T cell. The canonical TCR signaling pathway relies on early activation of the Src kinase LCK. This step initiates a cascade of events that lead not only to the phenotypic changes that characterize effector T cells but also to the activation of negative regulatory mechanisms that stop early TCR signaling. These mechanisms ensure qualitative and quantitative fine-tuning of T cell activation. The tyrosine phosphatase SHP-1 is a key player in the downregulation of LCK activation. In this review, we focus on the crosstalk between LCK and SHP-1 and, based on recent data, we introduce the putative kinase TAOK3 as an important regulator of this crosstalk. Given the widespread expression of TAOK3 and SHP-1, we propose that the function of TAOK3 extends beyond T cells and may be fundamental in the regulation of early signaling from receptors that utilize Src kinases.
Insights
T cell receptor (TCR) signaling is fine-tuned by negative regulators like SHP-1 phosphatase. This review highlights TAOK3 kinase as a novel regulator of the LCK-SHP-1 crosstalk, impacting T cell activation.
Area of Science:
- Immunology
- Cellular Signaling
- Molecular Biology
Background:
- T cell activation relies on T cell receptor (TCR) signaling, initiated by LCK kinase.
- Negative regulatory mechanisms fine-tune TCR signaling, involving the tyrosine phosphatase SHP-1 to downregulate LCK.
- Understanding these regulatory pathways is crucial for controlling T cell responses.
Purpose of the Study:
- To review the crosstalk between LCK and SHP-1 in TCR signaling.
- To introduce the kinase TAOK3 as a novel regulator of the LCK-SHP-1 interaction.
- To explore the broader implications of TAOK3 in Src kinase-dependent signaling.
Main Methods:
- Literature review focusing on TCR signaling pathways.
- Analysis of recent data on LCK, SHP-1, and TAOK3 interactions.
- In silico analysis and pathway modeling (implied).
Main Results:
- LCK activation is a critical early step in TCR signaling.
- SHP-1 negatively regulates LCK activity.
- Recent data suggests TAOK3 kinase plays a significant role in modulating the LCK-SHP-1 crosstalk.
Conclusions:
- TAOK3 is proposed as a key regulator of the LCK-SHP-1 axis in T cells.
- The widespread expression of TAOK3 suggests its fundamental role in regulating early signaling pathways involving Src kinases beyond T cells.
- This finding opens new avenues for understanding and potentially manipulating immune cell responses.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
Receptor Tyrosine Kinases
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
MAPK Signaling Cascades

